Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 12436116 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | streptococcal infections | NA | NA | NA | unclassified | |
| we propose that human leukocyte antigen class ii allelic variation contributes to differences in severity of invasive streptococcal infections through their ability to regulate cytokine responses triggered by streptococcal superantigens. | |||||||
| 12452995 | HLA-DRB1*08 | hypomelanosis | NA | NA | NA | unclassified | |
| hla-dq3 is associated with idiopathic guttate hypomelanosis, whereas hla-dr8 is not, in a group of renal transplant patients. | |||||||
| 12452995 | HLA-DQA1*03 | hypomelanosis | NA | NA | NA | unclassified | |
| hla-dq3 is associated with idiopathic guttate hypomelanosis, whereas hla-dr8 is not, in a group of renal transplant patients. | |||||||
| 24387680 | HLA-DR (HLA-DR) | secondary infections | NA | NA | NA | unclassified | |
| in addition, donors with the highest cd8 pd-1 expression together with the lowest cd8 pd-l1 expression also had lower levels of hla-dr expression in monocytes, and an increased rate of secondary infections, suggestive of a more immune exhausted phenotype. | |||||||
| 19031816 | HLA-DRB1 (HLA-DRB1) | aggressive periodontitis | NA | vitamin | NA | positive | |
| the frequencies of homozygous for hla-drb1* 1501 allele, tnf-a-308 allele ii, il-1b(+3953) allele ii, vitamin d receptor allele a, t, estrogen receptor allele x in generalized aggressive periodontitis patients were higher than those in healthy controls. | |||||||
| 19031816 | HLA-DRB1 (HLA-DRB1) | aggressive periodontitis | NA | vitamin | NA | unclassified | |
| hla-drb1 * 1501 allele, tnfa-308 allele ii, il-1b(+3953) allele ii, vitamin d receptor allele a, t, estrogen receptor allele x are susceptible alleles in generalized aggressive periodontitis. | |||||||
| 20073992 | HLA-B*40 | lipodystrophy | NA | stavudine | NA | unclassified | |
| association between hla-b*4001 and lipodystrophy among hiv-infected patients from thailand who received a stavudine-containing antiretroviral regimen. | |||||||
| 20073992 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lipodystrophy | NA | stavudine | NA | unclassified | |
| the aim of this study was to determine the clinical risk factors and human leukocyte antigen (hla) alleles associated with stavudine-associated lipodystrophy. | |||||||
| 20073992 | HLA-DPB1 (HLA-DPB1) | lipodystrophy | NA | stavudine | NA | unclassified | |
| the clinical characteristics and allelic distribution of hla-a, hla-b, hla-c, hla-drb1, hla-dqb1, and hla-dpb1 were compared between the case group and the control group, to determine the possible association with stavudine-associated lipodystrophy. | |||||||
| 20073992 | HLA-A (HLA-A) | lipodystrophy | NA | stavudine | NA | unclassified | |
| the clinical characteristics and allelic distribution of hla-a, hla-b, hla-c, hla-drb1, hla-dqb1, and hla-dpb1 were compared between the case group and the control group, to determine the possible association with stavudine-associated lipodystrophy. | |||||||
Copyright 2024